Published in Am J Epidemiol on June 20, 2007
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol (2009) 2.46
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Uric acid as a CNS antioxidant. J Alzheimers Dis (2010) 1.93
Prospective study of statin use and risk of Parkinson disease. Arch Neurol (2012) 1.76
Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology (2012) 1.72
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol (2009) 1.56
Recreational physical activity and risk of Parkinson's disease. Mov Disord (2008) 1.45
Physical activities and future risk of Parkinson disease. Neurology (2010) 1.42
Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov Disord (2012) 1.36
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol (2014) 1.16
Plasma urate and progression of mild cognitive impairment. Neurodegener Dis (2008) 1.16
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog Neurobiol (2011) 1.14
Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Ann Neurol (2013) 1.14
Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med (2010) 1.13
A molecular signature in blood identifies early Parkinson's disease. Mol Neurodegener (2012) 1.13
Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res (2010) 1.13
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care (2011) 1.09
Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet (2012) 1.08
Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta (2008) 1.08
Gene-environment interactions in Parkinson's disease: the importance of animal modeling. Clin Pharmacol Ther (2010) 1.07
Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim Biophys Acta (2013) 1.04
Plasma urate and Parkinson's disease in women. Am J Epidemiol (2010) 1.03
Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother (2010) 1.01
Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol (2012) 0.97
Biological fluid biomarkers in neurodegenerative parkinsonism. Nat Rev Neurol (2009) 0.96
Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology (2016) 0.96
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect (2008) 0.94
Uric acid and dementia in community-dwelling older persons. Dement Geriatr Cogn Disord (2009) 0.93
Unbiased approaches to biomarker discovery in neurodegenerative diseases. Neuron (2014) 0.93
Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease. PLoS One (2012) 0.93
Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics (2014) 0.92
The risk of Parkinson disease associated with urate in a community-based cohort of older adults. Neuroepidemiology (2011) 0.92
Serum urate and probability of dopaminergic deficit in early "Parkinson's disease". Mov Disord (2011) 0.90
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord (2012) 0.90
Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis. J Neurol (2014) 0.90
Mendelian randomization of serum urate and parkinson disease progression. Ann Neurol (2014) 0.89
Blood-based biomarkers for Parkinson's disease. Parkinsonism Relat Disord (2014) 0.88
Premotor biomarkers for Parkinson's disease - a promising direction of research. Transl Neurodegener (2012) 0.86
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection. Parkinsons Dis (2010) 0.86
An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis. J Neurol (2010) 0.86
Protection of dopaminergic cells by urate requires its accumulation in astrocytes. J Neurochem (2012) 0.86
Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population. J Neurol (2013) 0.86
Diethylstilbestrol exposure in utero and depression in women. Am J Epidemiol (2010) 0.83
Parkinson's disease. Subcell Biochem (2012) 0.82
Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients. Mov Disord (2015) 0.82
Particulate matter and risk of Parkinson disease in a large prospective study of women. Environ Health (2014) 0.82
Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy. EPMA J (2010) 0.81
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am (2014) 0.81
Reassessing serum urate targets in the management of refractory gout: can you go too low? Curr Opin Rheumatol (2009) 0.81
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies. BMC Neurol (2015) 0.81
Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology. Transl Neurodegener (2014) 0.80
Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases. Neurotherapeutics (2009) 0.80
Alcohol Consumption, Types of Alcohol, and Parkinson's Disease. PLoS One (2013) 0.79
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications. Antioxid Redox Signal (2015) 0.79
The effects of uric Acid, serum vitamin d3, and their interaction on Parkinson's disease severity. Parkinsons Dis (2015) 0.79
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study. Ann Rheum Dis (2015) 0.79
Ambient Air Pollution Exposures and Risk of Parkinson Disease. Environ Health Perspect (2016) 0.79
Postmortem brain levels of urate and precursors in Parkinson's disease and related disorders. Neurodegener Dis (2013) 0.78
Identification of key uric acid synthesis pathway in a unique mutant silkworm Bombyx mori model of Parkinson's disease. PLoS One (2013) 0.78
Biochemical premotor biomarkers for Parkinson's disease. Mov Disord (2012) 0.78
Urate as a Marker of Risk and Progression of Neurodegenerative Disease. Neurotherapeutics (2016) 0.78
Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease. Brain Res (2014) 0.78
Gout and the risk of Parkinson's disease in Denmark. Eur J Epidemiol (2013) 0.78
NMR Metabolomics Analysis of Parkinson's Disease. Curr Metabolomics (2015) 0.77
Short communication: genetic variations of SLC2A9 in relation to Parkinson's disease. Transl Neurodegener (2013) 0.77
Therapeutic directions for Parkinson's disease. Mov Disord (2010) 0.76
Intake of dairy foods and risk of Parkinson disease. Neurology (2017) 0.75
Protection by inosine in a cellular model of Parkinson's disease. Neuroscience (2014) 0.75
Purines: forgotten mediators in traumatic brain injury. J Neurochem (2016) 0.75
Re: "plasma urate and risk of Parkinson's disease". Am J Epidemiol (2008) 0.75
Serum uric acid levels in Parkinson's disease and related disorders. Brain Behav (2016) 0.75
Sex-specific Association Between Uric Acid and Outcomes After Acute Ischemic Stroke: A Prospective Study from CATIS Trial. Sci Rep (2016) 0.75
Relationship between uric acid levels and progressive supranuclear palsy. Mov Disord (2016) 0.75
Uricosuric targets of tranilast. Pharmacol Res Perspect (2017) 0.75
Micronutrients and Risk of Parkinson's Disease: A Systematic Review. Gerontol Geriatr Med (2016) 0.75
Blood biomarker for Parkinson disease: peptoids. NPJ Parkinsons Dis (2016) 0.75
Low uric acid is a risk factor in mild cognitive impairment. Neuropsychiatr Dis Treat (2017) 0.75
Long-term exposure to air pollution and the incidence of Parkinson's disease: A nested case-control study. PLoS One (2017) 0.75
A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study. PLoS One (2017) 0.75
Impact of serum uric acid, albumin and their interaction on Parkinson's disease. Neurol Sci (2016) 0.75
Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol (2017) 0.75
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A (1981) 8.45
Oxidative stress in Parkinson's disease. Ann Neurol (2003) 5.93
Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med (1999) 4.88
Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci (1999) 3.57
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology (2001) 3.25
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09
Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol (2005) 2.54
Serum uric acid levels and the risk of Parkinson disease. Ann Neurol (2005) 2.47
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1998) 2.21
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A (1996) 2.10
Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol (1996) 2.08
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem (2002) 1.99
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J (1986) 1.94
The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses (2001) 1.74
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem (1991) 1.70
Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys (2000) 1.62
Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation. Brain Res Bull (1994) 1.39
A reassessment of the peroxynitrite scavenging activity of uric acid. Ann N Y Acad Sci (2002) 1.26
Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol (2002) 1.23
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A (2002) 1.22
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14
The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease. J Neural Transm Park Dis Dement Sect (1993) 1.14
Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol (2001) 1.11
Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet (1999) 1.09
Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med (2002) 1.05
Effect of inosine supplementation on aerobic and anaerobic cycling performance. Med Sci Sports Exerc (1996) 1.01
Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Mult Scler (2001) 1.00
Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biol Psychiatry (1984) 1.00
Serum uric acid and multiple sclerosis. Neurol Sci (2002) 0.99
Dopamine and uric acid act as antioxidants in the repair of DNA radicals: implications in Parkinson's disease. Free Radic Res (2003) 0.98
Serum uric acid levels in optic neuritis. Mult Scler (2004) 0.94
[Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease]. Rev Esp Salud Publica (2001) 0.88
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature (2004) 16.76
Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 9.76
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res (1997) 7.95
Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92
Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature (1995) 5.91
Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78
Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell (1998) 5.78
Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
Genetic diversity and disease control in rice. Nature (2000) 5.34
Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17
A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell (1999) 5.07
Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature (1995) 4.93
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol (2000) 4.75
Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49
Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46
Vitamin D intake and incidence of multiple sclerosis. Neurology (2004) 4.39
Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37
A transcriptional switch mediated by cofactor methylation. Science (2001) 4.32
Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29
A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 4.12
Physical activity and risk of stroke in women. JAMA (2000) 3.95
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91
Superconductivity at 43 K in SmFeAsO1-xFx. Nature (2008) 3.80
Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
Generation of coated intermediates of clathrin-mediated endocytosis on protein-free liposomes. Cell (1998) 3.62
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology (2006) 3.59
Prospective study of military service and mortality from ALS. Neurology (2005) 3.59
Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell (2000) 3.59
Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science (1997) 3.59
Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol (2005) 3.51
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med (1997) 3.48
A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell (1999) 3.36
A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst (1994) 3.32
A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28
Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst (1995) 3.24
Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA (1999) 3.21
Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature (1997) 3.14
The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol (2007) 3.12
Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer (1999) 3.06
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res (1994) 2.84
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem (1996) 2.75
Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med (1998) 2.64
The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol (1991) 2.63
Adiposity and mortality in men. Am J Epidemiol (2000) 2.60
The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58
Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature (2000) 2.57
Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J (2000) 2.53
Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol (1997) 2.51
Phenotypes Associated with SHOX Deficiency. J Clin Endocrinol Metab (2001) 2.51
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer (1999) 2.49
Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J Virol (2006) 2.47
Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol (2001) 2.42
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42
Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology (2008) 2.41
Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene (2011) 2.36
Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect (2011) 2.29
An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature (1997) 2.29
Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem (1995) 2.28
Establishment of influenza A virus (H6N1) in minor poultry species in southern China. J Virol (2007) 2.26
Family history of melanoma and Parkinson disease risk. Neurology (2009) 2.25
Colloid cyst of the third ventricle: imaging-pathologic correlation. AJNR Am J Neuroradiol (2000) 2.23
Two-dimensional imaging through diffusing media using 150-fs gated electronic holography techniques. Opt Lett (1991) 2.21
A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci (2000) 2.20
Nitrogen fixation ability of exopolysaccharide synthesis mutants of Rhizobium sp. strain NGR234 and Rhizobium trifolii is restored by the addition of homologous exopolysaccharides. J Bacteriol (1987) 2.17
Hemiballismus. AJNR Am J Neuroradiol (1994) 2.16
Evolutionary insights into the ecology of coronaviruses. J Virol (2007) 2.16
Crystal structure of a human TATA box-binding protein/TATA element complex. Proc Natl Acad Sci U S A (1996) 2.15
Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem (1998) 2.13
Squeezing axons out of the gray matter: a role for slit and semaphorin proteins from midline and ventral spinal cord. Cell (2000) 2.11
Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation (1994) 2.10
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med (1999) 2.07
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell (1996) 2.04
The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology (2008) 2.04
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum (1998) 2.00
Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr (1999) 1.99
Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr (2000) 1.99
Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica (1997) 1.98
Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem (2001) 1.98
Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci U S A (1997) 1.97
Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. Annu Rev Nutr (2005) 1.97
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96